NasdaqGS - Nasdaq Real Time Price USD

Apyx Medical Corporation (APYX)

1.3100 +0.0500 (+3.73%)
As of 12:16 PM EDT. Market Open.
Loading Chart for APYX
DELL
  • Previous Close 1.2600
  • Open 1.2800
  • Bid 1.2600 x 100
  • Ask 1.6700 x 200
  • Day's Range 1.2800 - 1.4700
  • 52 Week Range 1.2100 - 7.9700
  • Volume 30,737
  • Avg. Volume 157,279
  • Market Cap (intraday) 45.384M
  • Beta (5Y Monthly) 1.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5400
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.63

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

apyxmedical.com

252

Full Time Employees

December 31

Fiscal Year Ends

Recent News: APYX

Q4 2023 Apyx Medical Corp Earnings Call

Performance Overview: APYX

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APYX
50.00%
S&P 500
6.23%

1-Year Return

APYX
54.83%
S&P 500
22.58%

3-Year Return

APYX
86.75%
S&P 500
22.54%

5-Year Return

APYX
66.24%
S&P 500
74.25%

Compare To: APYX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: APYX

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    44.17M

  • Enterprise Value

    39.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    1.65

  • Enterprise Value/Revenue

    0.75

  • Enterprise Value/EBITDA

    -2.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -35.75%

  • Return on Assets (ttm)

    -18.80%

  • Return on Equity (ttm)

    -58.25%

  • Revenue (ttm)

    52.35M

  • Net Income Avi to Common (ttm)

    -18.71M

  • Diluted EPS (ttm)

    -0.5400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.65M

  • Total Debt/Equity (mrq)

    143.01%

  • Levered Free Cash Flow (ttm)

    3.37M

Research Analysis: APYX

Analyst Price Targets

2.00
3.63 Average
1.3100 Current
8.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: APYX

Fair Value

1.3100 Current
 

Dividend Score

0 Low
APYX
Sector Avg.
100 High
 

Hiring Score

0 Low
APYX
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
APYX
Sector Avg.
100 High
 

People Also Watch